GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP) (A1AGS9)

Analyse AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A1AGS9
Type
protein
Length
540 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x4bC225Cd2778aD8b434c09FeFE8BcBb702fea729
Molecule
Phosphoenolpyruvate carboxykinase (ATP)
UniProt
A1AGS9
Pockets
2 · best druggability 0.73

Structure

1 distinct chain · 30% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphoenolpyruvate carboxykinase (ATP)protein54030% helix, 24% strandA1AGS9

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14790.730.8270empty
2990.390.7620empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.